Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis (Q90172065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

title

Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Chong-Ge You

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Xiao-Fei Feng

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

Wan-Xia Yang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

publication date

25 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

BioMed Research International

11 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

volume

2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

page(s)

1093815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

11 April 2020

copyright license

start time

25 August 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

describes a project that uses

limma

object named as

limma

2 references

22 June 2022

https://europepmc.org/article/PMC/6732589

inferred from PubMed Central ID database lookup

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

1 reference

12 December 2020

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

1 reference

12 December 2020

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity

1 reference

12 December 2020

KEGG: kyoto encyclopedia of genes and genomes

1 reference

12 December 2020

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

12 December 2020

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

12 December 2020

Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder.

1 reference

12 December 2020

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

1 reference

12 December 2020

Combinatorial patterns of somatic gene mutations in cancer

1 reference

12 December 2020

The complexity of the complicity of mast cells in cancer

1 reference

12 December 2020

T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy

1 reference

12 December 2020

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

1 reference

12 December 2020

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.

1 reference

12 December 2020

clusterProfiler: an R package for comparing biological themes among gene clusters.

1 reference

12 December 2020

T-helper-1-cell cytokines drive cancer into senescence

1 reference

12 December 2020

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 reference

12 December 2020

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

12 December 2020

The Cancer Genome Atlas Pan-Cancer analysis project

1 reference

12 December 2020

Optimal treatment of non-muscle invasive urothelial carcinoma including perioperative management revisited

1 reference

12 December 2020

Genetic basis for clinical response to CTLA-4 blockade in melanoma

1 reference

12 December 2020

Gene Ontology Consortium: going forward

1 reference

12 December 2020

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

1 reference

12 December 2020

limma powers differential expression analyses for RNA-sequencing and microarray studies

1 reference

12 December 2020

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

1 reference

12 December 2020

Robust enumeration of cell subsets from tissue expression profiles

1 reference

12 December 2020

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

1 reference

12 December 2020

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

1 reference

12 December 2020

Emerging role of immunotherapy in urothelial carcinoma-Advanced disease

1 reference

12 December 2020

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

1 reference

12 December 2020

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

1 reference

12 December 2020

Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer

1 reference

12 December 2020

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

1 reference

12 December 2020

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

1 reference

12 December 2020

Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity.

1 reference

12 December 2020

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand (PD-L)-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

1 reference

12 December 2020

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

1 reference

12 December 2020

Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study

1 reference

12 December 2020

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

1 reference

12 December 2020

Maftools: efficient and comprehensive analysis of somatic variants in cancer

1 reference

12 December 2020

Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway

1 reference

12 December 2020

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

1 reference

12 December 2020

Classification of triple-negative breast cancers based on Immunogenomic profiling

1 reference

12 December 2020

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

1 reference

12 December 2020

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

1 reference

12 December 2020

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

1 reference

12 December 2020

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

1 reference

12 December 2020

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

1 reference

12 December 2020

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1155/2019/1093815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31534952%20AND%20SRC:MED&resulttype=core&format=json

11 April 2020

1 reference